<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">23961958</PMID><DateCompleted><Year>2014</Year><Month>03</Month><Day>03</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2334</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><PubDate><Year>2013</Year><Month>Aug</Month><Day>20</Day></PubDate></JournalIssue><Title>BMC infectious diseases</Title><ISOAbbreviation>BMC Infect Dis</ISOAbbreviation></Journal><ArticleTitle>Proteomic analysis of extremely severe hand, foot and mouth disease infected by enterovirus 71.</ArticleTitle><Pagination><StartPage>383</StartPage><MedlinePgn>383</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/1471-2334-13-383</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">To clarify the molecular mechanisms that participate in the severe hand, foot and mouth disease (HFMD) infected by Enterovirus 71 and to detect any related protein biomarkers, we performed proteomic analysis of protein extracts from 5 extremely severe HFMD children and 5 healthy children.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The protein profiles of them were compared using two-dimensional electrophoresis. Differentially expressed proteins were identified using mass spectrometry. Functional classifications of these proteins were based on the PANTHER. The interaction network of the differentially expressed protein was generated with Pathway Studio.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 38 differentially expressed proteins were identified. Functional classifications of these proteins indicated a series of altered cellular processes as a consequence of the severe HFMD. These results provided not only new insights into the pathogenesis of severe HFMD, but also implications of potential therapeutic designs.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our results suggested the possible pathways that could be the potential targets for novel therapy: viral protection, complement system and peroxide elimination.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Deng</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Guangzhou Women and Children&#x2032;s Medical Center, Guangzhou 510120, Guangdong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jia</LastName><ForeName>Hong-Ling</ForeName><Initials>HL</Initials></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Chao-Wu</ForeName><Initials>CW</Initials></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Yu-Fen</ForeName><Initials>YF</Initials></Author><Author ValidYN="Y"><LastName>Mao</LastName><ForeName>Li-Jia</ForeName><Initials>LJ</Initials></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Chun-Hui</ForeName><Initials>CH</Initials></Author><Author ValidYN="Y"><LastName>Yin</LastName><ForeName>Gen-Quan</ForeName><Initials>GQ</Initials></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Jun-Hong</ForeName><Initials>JH</Initials></Author><Author ValidYN="Y"><LastName>Tao</LastName><ForeName>Jian-Ping</ForeName><Initials>JP</Initials></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Li</ForeName><Initials>L</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>08</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Infect Dis</MedlineTA><NlmUniqueID>100968551</NlmUniqueID><ISSNLinking>1471-2334</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001798">Blood Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020543">Proteome</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001798" MajorTopicYN="N">Blood Proteins</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015153" MajorTopicYN="N">Blotting, Western</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015180" MajorTopicYN="N">Electrophoresis, Gel, Two-Dimensional</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="Y">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006232" MajorTopicYN="N">Hand, Foot and Mouth Disease</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060066" MajorTopicYN="N">Protein Interaction Maps</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020543" MajorTopicYN="N">Proteome</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D040901" MajorTopicYN="N">Proteomics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019032" MajorTopicYN="N">Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>3</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2013</Year><Month>8</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>8</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>8</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>3</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2013</Year><Month>8</Month><Day>20</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23961958</ArticleId><ArticleId IdType="pmc">PMC3765220</ArticleId><ArticleId IdType="doi">10.1186/1471-2334-13-383</ArticleId><ArticleId IdType="pii">1471-2334-13-383</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Schmidt NJ, Lennette EH, Ho HH. An apparently new enterovirus isolated from patients with disease of the central nervous system. J Infect Dis. 1974;129(3):304&#x2013;309. doi: 10.1093/infdis/129.3.304.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/129.3.304</ArticleId><ArticleId IdType="pubmed">4361245</ArticleId></ArticleIdList></Reference><Reference><Citation>Lum LC, Wong KT, Lam SK, Chua KB, Goh AY, Lim WL, Ong BB, Paul G, AbuBakar S, Lambert M. Fatal enterovirus 71 encephalomyelitis. J Pediatr. 1998;133(6):795&#x2013;798. doi: 10.1016/S0022-3476(98)70155-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-3476(98)70155-6</ArticleId><ArticleId IdType="pubmed">9842048</ArticleId></ArticleIdList></Reference><Reference><Citation>Lum LC, Wong KT, Lam SK, Chua KB, Goh AY. Neurogenic pulmonary oedema and enterovirus 71 encephalomyelitis. Lancet. 1998;352(9137):1391.</Citation><ArticleIdList><ArticleId IdType="pubmed">9802304</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho M, Chen ER, Hsu KH, Twu SJ, Chen KT, Tsai SF, Wang JR, Shih SR. An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group. N Engl J Med. 1999;341(13):929&#x2013;935. doi: 10.1056/NEJM199909233411301.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199909233411301</ArticleId><ArticleId IdType="pubmed">10498487</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan KP, Goh KT, Chong CY, Teo ES, Lau G, Ling AE. Epidemic hand, foot and mouth disease caused by human enterovirus 71, Singapore. Emerg Infect Dis. 2003;9(1):78&#x2013;85. doi: 10.3201/eid0901.020112.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid0901.020112</ArticleId><ArticleId IdType="pmc">PMC2873753</ArticleId><ArticleId IdType="pubmed">12533285</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Tan XJ, Wang HY, Yan DM, Zhu SL, Wang DY, Ji F, Wang XJ, Gao YJ, Chen L. et al.An outbreak of hand, foot, and mouth disease associated with subgenotype C4 of human enterovirus 71 in Shandong. China. J Clin Virol. 2009;44(4):262&#x2013;267. doi: 10.1016/j.jcv.2009.02.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2009.02.002</ArticleId><ArticleId IdType="pubmed">19269888</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Zhu Z, Yang W, Ren J, Tan X, Wang Y, Mao N, Xu S, Zhu S, Cui A. An emerging recombinant human enterovirus 71 responsible for the 2008 outbreak of hand foot and mouth disease in Fuyang city of China. Virol J. 2008;7:94.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2885340</ArticleId><ArticleId IdType="pubmed">20459851</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia L, Zhao CS, Zhang L, Li S, Zhang DT, Liu BW, Wang QY, Li XY. [Comparisons of epidemiological and clinical characteristics in children with hand-foot-mouth disease caused by Enterovirus 71 and Coxackievirus A16] Zhongguo Dang Dai Er Ke Za Zhi. 2011;13(8):635&#x2013;637.</Citation><ArticleIdList><ArticleId IdType="pubmed">21849112</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Zhu C, Bao W, Zhao K, Niu J, Yu XF, Zhang W. Characterization of full-length enterovirus 71 strains from severe and mild disease patients in northeastern China. PLoS One. 2012;7(3):e32405. doi: 10.1371/journal.pone.0032405.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0032405</ArticleId><ArticleId IdType="pmc">PMC3315555</ArticleId><ArticleId IdType="pubmed">22479324</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang SM, Liu CC. Enterovirus 71: epidemiology, pathogenesis and management. Expert Rev Anti Infect Ther. 2009;7(6):735&#x2013;742. doi: 10.1586/eri.09.45.</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/eri.09.45</ArticleId><ArticleId IdType="pubmed">19681701</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen SC, Chang HL, Yan TR, Cheng YT, Chen KT. An eight-year study of epidemiologic features of enterovirus 71 infection in Taiwan. Am J Trop Med Hyg. 2007;77(1):188&#x2013;191.</Citation><ArticleIdList><ArticleId IdType="pubmed">17620652</ArticleId></ArticleIdList></Reference><Reference><Citation>Briese T, Palacios G, Kokoris M, Jabado O, Liu Z, Renwick N, Kapoor V, Casas I, Pozo F, Limberger R. et al.Diagnostic system for rapid and sensitive differential detection of pathogens. Emerg Infect Dis. 2005;11(2):310&#x2013;313. doi: 10.3201/eid1102.040492.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1102.040492</ArticleId><ArticleId IdType="pmc">PMC3320438</ArticleId><ArticleId IdType="pubmed">15752453</ArticleId></ArticleIdList></Reference><Reference><Citation>Foo DG, Ang RX, Alonso S, Chow VT, Quak SH, Poh CL. Identification of immunodominant VP1 linear epitope of enterovirus 71 (EV71) using synthetic peptides for detecting human anti-EV71 IgG antibodies in Western blots. Clin Microbiol Infect. 2008;14(3):286&#x2013;288. doi: 10.1111/j.1469-0691.2007.01904.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1469-0691.2007.01904.x</ArticleId><ArticleId IdType="pubmed">18076666</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang SY, Lin TL, Chen HY, Lin TS. Early and rapid detection of enterovirus 71 infection by an IgM-capture ELISA. J Virol Methods. 2004;119(1):37&#x2013;43. doi: 10.1016/j.jviromet.2004.02.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jviromet.2004.02.017</ArticleId><ArticleId IdType="pubmed">15109819</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu F, Yan Q, Wang H, Niu J, Li L, Zhu F, He S, Zhang S, Weng Z, Cheng T. Performance of detecting IgM antibodies against enterovirus 71 for early diagnosis. PLoS One. 2010;5(6):e11388. doi: 10.1371/journal.pone.0011388.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0011388</ArticleId><ArticleId IdType="pmc">PMC2894942</ArticleId><ArticleId IdType="pubmed">20613983</ArticleId></ArticleIdList></Reference><Reference><Citation>Sherman M, Peltekian KM, Lee C. Screening for hepatocellular carcinoma in chronic carriers of hepatitis B virus: incidence and prevalence of hepatocellular carcinoma in a North American urban population. Hepatology. 1995;22(2):432&#x2013;438.</Citation><ArticleIdList><ArticleId IdType="pubmed">7543434</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia H, Liu C, Ge F, Xiao C, Lu C, Wang T, He Q. Identification of ubiquitinated proteins from human multiple myeloma U266 cells by proteomics. Biomed Environ Sci. 2011;24(4):422&#x2013;430.</Citation><ArticleIdList><ArticleId IdType="pubmed">22108332</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao CL, Zhang ZP, Xiong S, Lu CH, Wei HP, Zeng HL, Liu Z, Zhang XE, Ge F. Comparative proteomic analysis to discover potential therapeutic targets in human multiple myeloma. Proteomics Clin Appl. 2009;3(11):1348&#x2013;1360. doi: 10.1002/prca.200900068.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/prca.200900068</ArticleId><ArticleId IdType="pubmed">21136955</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng L, Jia HL, Liu CW, Hu KH, Yin GQ, Ye JW, He CH, Chen JH, Xie YP, Dang R. Analysis of differentially expressed proteins involved in hand, foot and mouth disease and normal sera. Clin Microbiol Infect. 2012;18(6):E188&#x2013;196. doi: 10.1111/j.1469-0691.2012.03836.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1469-0691.2012.03836.x</ArticleId><ArticleId IdType="pubmed">22497606</ArticleId></ArticleIdList></Reference><Reference><Citation>Enghild JJ, Salvesen G, Thogersen IB, Valnickova Z, Pizzo SV, Hefta SA. Presence of the protein-glycosaminoglycan-protein covalent cross-link in the inter-alpha-inhibitor-related proteinase inhibitor heavy chain 2/bikunin. J Biol Chem. 1993;268(12):8711&#x2013;8716.</Citation><ArticleIdList><ArticleId IdType="pubmed">7682553</ArticleId></ArticleIdList></Reference><Reference><Citation>Sunthornthepvarakul T, Angkeow P, Weiss RE, Hayashi Y, Refetoff S. An identical missense mutation in the albumin gene results in familial dysalbuminemic hyperthyroxinemia in 8 unrelated families. Biochem Biophys Res Commun. 1994;202(2):781&#x2013;787. doi: 10.1006/bbrc.1994.1998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/bbrc.1994.1998</ArticleId><ArticleId IdType="pubmed">8048949</ArticleId></ArticleIdList></Reference><Reference><Citation>Ichinose A, Espling ES, Takamatsu J, Saito H, Shinmyozu K, Maruyama I, Petersen TE, Davie EW. Two types of abnormal genes for plasminogen in families with a predisposition for thrombosis. Proc Natl Acad Sci U S A. 1991;88(1):115&#x2013;119. doi: 10.1073/pnas.88.1.115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.88.1.115</ArticleId><ArticleId IdType="pmc">PMC50760</ArticleId><ArticleId IdType="pubmed">1986355</ArticleId></ArticleIdList></Reference><Reference><Citation>Sjoberg AP, Trouw LA, Blom AM. Complement activation and inhibition: a delicate balance. Trends Immunol. 2009;30(2):83&#x2013;90. doi: 10.1016/j.it.2008.11.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2008.11.003</ArticleId><ArticleId IdType="pubmed">19144569</ArticleId></ArticleIdList></Reference><Reference><Citation>Ricklin D, Hajishengallis G, Yang K, Lambris JD. Complement: a key system for immune surveillance and homeostasis. Nat Immunol. 2010;11(9):785&#x2013;797. doi: 10.1038/ni.1923.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.1923</ArticleId><ArticleId IdType="pmc">PMC2924908</ArticleId><ArticleId IdType="pubmed">20720586</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang C, Xu Y, Jia L, Yang Y, Wang Y, Sun Y, Huang L, Qiao F, Tomlinson S, Liu X. A new therapeutic strategy for lung tissue injury induced by influenza with CR2 targeting complement inhibitor. Virol J. 2010;7:30. doi: 10.1186/1743-422X-7-30.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-7-30</ArticleId><ArticleId IdType="pmc">PMC2829536</ArticleId><ArticleId IdType="pubmed">20144216</ArticleId></ArticleIdList></Reference><Reference><Citation>Shih SR, Stollar V, Lin JY, Chang SC, Chen GW, Li ML. Identification of genes involved in the host response to enterovirus 71 infection. J Neurovirol. 2004;10(5):293&#x2013;304. doi: 10.1080/13550280490499551.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13550280490499551</ArticleId><ArticleId IdType="pubmed">15385252</ArticleId></ArticleIdList></Reference><Reference><Citation>Crack PJ, Taylor JM, Flentjar NJ, De Haan J, Hertzog P, Iannello RC, Kola I. Increased infarct size and exacerbated apoptosis in the glutathione peroxidase-1 (Gpx-1) knockout mouse brain in response to ischemia/reperfusion injury. J Neurochem. 2001;78(6):1389&#x2013;1399. doi: 10.1046/j.1471-4159.2001.00535.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1471-4159.2001.00535.x</ArticleId><ArticleId IdType="pubmed">11579147</ArticleId></ArticleIdList></Reference><Reference><Citation>Hussain SP, Amstad P, He P, Robles A, Lupold S, Kaneko I, Ichimiya M, Sengupta S, Mechanic L, Okamura S. et al.p53-induced up-regulation of MnSOD and GPx but not catalase increases oxidative stress and apoptosis. Cancer Res. 2004;64(7):2350&#x2013;2356. doi: 10.1158/0008-5472.CAN-2287-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-2287-2</ArticleId><ArticleId IdType="pubmed">15059885</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuku I, Aydogdu I, Bayraktar N, Kaya E, Akyol O, Erkurt MA. Oxidant/antioxidant parameters and their relationship with medical treatment in multiple myeloma. Cell Biochem Funct. 2005;23(1):47&#x2013;50. doi: 10.1002/cbf.1127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cbf.1127</ArticleId><ArticleId IdType="pubmed">15386538</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>